Mechanistic systems modeling to guide drug discovery and development

  • Schmidt B
  • Papin J
  • Musante C
  • 102


    Mendeley users who have this article in their library.
  • 28


    Citations of this article.


A crucial question that must be addressed in the drug development process is whether the proposed therapeutic target will yield the desired effect in the clinical population. Pharmaceutical and biotechnology companies place a large investment on research and development, long before confirmatory data are available from human trials. Basic science has greatly expanded the computable knowledge of disease processes, both through the generation of large omics data sets and a compendium of studies assessing cellular and systemic responses to physiologic and pathophysiologic stimuli. Given inherent uncertainties in drug development, mechanistic systems models can better inform target selection and the decision process for advancing compounds through preclinical and clinical research. © 2012 Elsevier Ltd.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Brian J. Schmidt

  • Jason A. Papin

  • Cynthia J. Musante

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free